Showing 981 - 1,000 results of 135,496 for search '(( 2 c decrease ) OR ( 5 ((((a decrease) OR (we decrease))) OR (mean decrease)) ))', query time: 1.82s Refine Results
  1. 981
  2. 982
  3. 983
  4. 984

    Supplementary Material for: Decreased Amino Acid Concentrations are Involved in Congenital Heart Disease by Lai G. (6518795)

    Published 2019
    “…When H9C2 cells were cultured in one-half AA concentrations, the expression of P300 and IGF1R was reduced. …”
  5. 985
  6. 986

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Data represent mean±S.D. C. Magnified image of green-boxed area 2 in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0003642#pone-0003642-g003" target="_blank">Figure 3A</a> shows morphology of dermal fibroblasts (red arrow) are spindle-shaped and often stellate with cytoplasmic extension in wild-type, while they are mostly round to oval in <i>Slc39a13</i>-KO mice. …”
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993
  14. 994
  15. 995

    The ratio between the bias in the naïve SI and shuffle SI decreases with tuning specificity, but not with sample size. by Liron Sheintuch (12078310)

    Published 2022
    “…Data pooled from N = 9 simulations, each corresponding to behavioral data from a different mouse. (B) The bias ratio (mean ± SEM) decreases as a function of the true SI for a sample size of 1 minute (blue), 5 minutes (cyan) and 20 minutes (green). …”
  16. 996
  17. 997

    vFLIP and vCyclin decrease SMAD2 protein expression and desensitize TGF-β signaling. by Hong Seok Choi (121525)

    Published 2015
    “…<p>(A) SMAD2 expression was drastically decreased upon the expression of vFLIP or vCyclin in SLK cells. …”
  18. 998
  19. 999
  20. 1000

    Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

    Published 2012
    “…<i>(B)</i> When the antagonist is administrated twice, intraocular pressure remains low during 6 weeks (n = 10 each); the black arrow indicates the period of retinal and visual <i>in vivo</i> testing presented in <i>Fig. 6A,B</i>. <i>(C)</i> Dose-dependent effect of two administrations of CXCR3 antagonist on intraocular pressure as tested two weeks after the treatment (n = 5 each). * <i>P</i><0.05, ** <i>P</i><0.01. …”